SCHEMBL24258491

SCHEMBL24258491

CNC(=O)N1CCOc2ccc(CCCCc3cc(-c4cnn(C)c4)c(C(F)F)cc3C)cc2C1

nearest known ligand 0.62

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 20/20 0.62
BRD4 O60885 6/20 0.61
EP300 Q09472 2/20 0.44
BRPF1 P55201 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258507 0.92 CREBBP (0.60) CREBBPBRD4EP300
SCHEMBL24258490 0.79 CREBBP (0.43) CREBBPBRD4
SCHEMBL19643782 0.76 CREBBP (1.00) CREBBPBRD4
SCHEMBL30117226 0.76 CREBBP (1.00) CREBBPBRD4
SCHEMBL19644157 0.76 CREBBP (1.00) CREBBPBRD4EP300BRPF1
SCHEMBL19657623 0.76 CREBBP (1.00) CREBBPBRD4
SCHEMBL19657918 0.75 CREBBP (0.42) CREBBPBRD4EP300
SCHEMBL19657389 0.70 CREBBP (0.40) CREBBPBRD4EP300
SCHEMBL21255156 0.70 CREBBP (0.41) CREBBPBRD4EP300
SCHEMBL19657663 0.70 CREBBP (0.43) CREBBPBRD4EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464270-B1 HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER GENENTECH INC (US) 2022-02-23 EP disclosed